Abstract
Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that open their ion-conducting pores in response to the binding of agonist glutamate. In recent years, significant progress has been achieved in studies of iGluRs by determining numerous structures of isolated water-soluble ligand-binding and amino-terminal domains, as well as solving the first crystal structure of the full-length AMPA receptor in the closed, antagonist-bound state. These structural data combined with electrophysiological and fluorescence recordings, biochemical experiments, mutagenesis and molecular dynamics simulations have greatly improved our understanding of iGluR assembly, activation and desensitization processes. This article reviews the recent structural and functional advances in the iGluR field and summarizes them in a simplified model of full-length iGluR gating.
Introduction
Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that mediate the majority of excitatory neurotransmission in the central nervous system (Traynelis et al. 2010). iGluRs are implicated in nearly all aspects of nervous system development and function, and their dysfunction is associated with devastating chronic neurodegenerative conditions such as Alzheimer's and Parkinson's diseases, psychiatric disorders such as schizophrenia and depression and acute disorders such as brain trauma and stroke (Bowie, 2008; Traynelis et al. 2010; Paoletti et al. 2013). The iGluR family includes three major subtypes: AMPA, kainate (KA) and NMDA receptors. Each subtype is represented by several subunits including GluA1–4 for AMPA receptors, GluK1–5 for KA receptors and GluN1, GluN2A–D and GluN3A–B for NMDA receptors. Although iGluR subtypes exhibit diverse kinetic and pharmacological properties and play disparate roles in cognition, they share common structural features.
iGluRs function as assemblies of four subunits. Whereas the majority of iGluRs in the nervous system are heterotetramers composed of at least two types of subunits, AMPA and select KA subunits can form functional homotetramers. Each iGluR subunit has a modular design (Fig. 1A) and includes a large extracellular amino-terminal domain (ATD) that plays a fundamental role in subtype-specific receptor assembly, trafficking and modulation; a ligand-binding domain (LBD) responsible for agonist/antagonist recognition; a transmembrane domain (TMD) that forms the membrane-spanning ion channel; and a cytoplasmic C-terminal domain (CTD) involved in synaptic localization, trafficking, mobility and receptor regulation. Structural information on iGluRs is limited to high resolution crystal structures of genetically excised, water-soluble ATDs (Furukawa, 2012) and LBDs (Gouaux, 2004) as well as the first 3.6 Å resolution crystal structure of the full-length AMPA receptor in the closed, antagonist bound state (Sobolevsky et al. 2009). This review discusses recent advances in the iGluR field and summarizes them in the context of the full-length receptor. Many important questions related to structure, function and assembly of iGluRs remain beyond the scope of this review but have been nicely reviewed elsewhere (Bowie, 2010; Jackson & Nicoll, 2011; Ogden & Traynelis, 2011; Paoletti, 2011; Lu & Roche, 2012; Popescu, 2012; Herguedas et al. 2013; Kumar & Mayer, 2013).
Figure 1. Structure of iGluR.
A, topology of iGluR subunit. B, structure of AMPA subtype rat GluA2 receptor in the closed antagonist bound state (3KG2). The four subunits (A to D) are coloured differently. The antagonist ZK 200775 molecules are shown as space-filling models. Strong and weak interfaces are shown as large and small ovals, respectively. C, model of the assembly of four three-compartmental sausages with strong interactions holding together (1) all four bottom compartments, (2) left and right pairs of the top compartments and (3) front and back pairs of the middle compartments. D, LBD–TMD linkers – the iGluR gating transmission domain – include S1–M1, M3–S2 and S2–M4, of which S1–M1 and S2–M4 are shown transparent. The M3–S2 linkers, the central element of the gating machinery, have different conformations and secondary structures for the two diagonal pairs of subunits, A/C and B/D.
Structure
The structure of the full-length AMPA receptor is shaped like the capital letter ‘Y’ with layered arrangement of domains: ATDs at the top, LBDs in the middle and TMDs at the bottom (Fig. 1B). TMDs of all four subunits assemble together to form a single ion channel. Interfaces between TMDs are the largest interfaces in the structure (∼2800 Å2 per subunit), suggesting strong contribution of the ion channel to the tetrameric stability of iGluR subunit assembly. Supporting this view, mutations at the TMD interfaces disrupt proper oligomerization of iGluR subunits (Salussolia et al. 2013) or produce drastic changes in the functional characteristics of the iGluR channel, such as single-channel conductance, allosteric modulation, alcohol sensitivity, Ca2+ permeability and ion channel block (Siegler Retchless et al. 2012; Lopez et al. 2013; Ren et al. 2013). ATDs and LBDs form two pairs of dimers each. The intradimer interfaces for ATD (∼1300 Å2 per dimer) and LBD (∼900 Å2 per dimer) are the next largest after the TMD interfaces and conclude the list of interfaces that mediate strong interactions between iGluR subunits.
The four iGluR subunits (A to D) form two conformationally distinct but chemically identical diagonal pairs (A/C and B/D) that underlie two fundamental properties of iGluR subunit assembly. First, they allow functionally important transformation of the fourfold rotational symmetry of the ion channel to the twofold rotational symmetry of the extracellular domains. The overall twofold rotational symmetry of the tetrameric iGluR is exceptional; generally, ion channels with n subunits per oligomer have n-fold rotational symmetry (Supplemental Fig. 1). Second, the conformationally different pairs of iGluR subunits underlie swapping of domains between dimers of ATD (AB and CD) and LBD (AD and BC). With domain swapping, the available number of strong intersubunit interactions is sufficient to keep the four iGluR subunits together (Fig. 1C). Such an assembly allows exceptional conformational flexibility, consistent with versatile physiological functions and regulation of iGluRs. In certain conditions, this flexibility might even be higher because of possible breakage of LBD intradimer interfaces leading to separation of LBDs (Schauder et al. 2013).
Several smaller interfaces also contribute to the stability of iGluR tetrameric assembly, possibly limiting its conformational flexibility: intrasubunit ATD–LBD interfaces in subunits A and C (∼300 Å2 per subunit) as well as interdimer interfaces between ATD dimers AB and CD (∼330 Å2) and between LBD dimers AD and BC (∼220 Å2). The intrasubunit ATD–LBD interfaces help maintain the upright orientation of these domains relative to one another, while the interdimer interfaces prevent ATD and LBD dimers from separating. Whether these dimers can separate from each other in other iGluR subtypes or gating conformations remains controversial. While one of the earlier electron microscopy (EM) studies proposed separation of ATD dimers during desensitization (Nakagawa et al. 2005), other EM studies (Midgett et al. 2012; Schauder et al. 2013) and crystallographic data (Clayton et al. 2009; Jin et al. 2009; Kumar et al. 2009, 2011; Kumar & Mayer, 2010) argue for the stability of the ATD dimer–dimer interface. On the other hand, several reported iGluR conformations have the LBD dimer–dimer interface either apparently modified (Lau et al. 2013) or absent (Midgett et al. 2012; Schauder et al. 2013).
Gating
The term ‘gating’ refers to a series of conformational changes in iGluR protein that relate the binding/unbinding of ligands to the opening/closure of the ion channel. Whole-cell currents in response to application of agonist glutamate reveal three apparent gating processes – activation, desensitization and deactivation (Fig. 2A) – that convert iGluR from closed to open, open to desensitized and open/desensitized to closed states (or gating conformations), respectively. Although detailed kinetic analysis of whole-cell and single-channel currents resolves many more gating conformations and the transitions between them (Popescu & Auerbach, 2003; Robert & Howe, 2003; Vance et al. 2013), the corresponding structural data remain limited.
Figure 2. Gating at the level of LBD.
A, whole-cell current recorded from HEK 293 cell expressing rat GluA2i. The current (courtesy of Dr Yelshansky, Columbia University) was elicited by a 500 ms application of glutamate (3 mm; filled bar) at a holding potential of −60 mV. B–D, back-to-back LBD dimers from the closed state structure of GluA2 (3KG2) bound to ZK 200775 (B) and from structures of the glutamate-bound isolated S1S2 in the presumed open (1FTJ; C) and desensitized (S729C mutant, 2I3W; D) states. The α-helical elements of secondary structure are labelled in B. Shown are distances between Cα's (spheres) of P632 and G739. Putative gating-associated movements of D1 and D2 are illustrated by red arrows.
Gating initiation domain: LBD – activation
iGluR activation begins with the binding of agonist glutamate to the clamshell-shaped gating initiation domain LBD. The LBD is formed by two stretches of polypeptide, S1, located between ATD and the first transmembrane domain M1, and S2, located between the transmembrane domains M3 and M4 (Fig. 1A). A construct of isolated S1 and S2 connected by a glycine–threonine linker (S1S2 construct) can be expressed in bacteria and folds into a bilobe structure of the ‘clamshell’ with the upper lobe D1 and lower lobe D2 (Armstrong & Gouaux, 2000). Since this soluble S1S2 construct is capable of binding different iGluR ligands and can be studied using X-ray crystallography and NMR, it has become a model system for understanding LBD structure–function relationships. Despite the power of this divide-and-conquer approach, the results of experiments with S1S2 should be interpreted with caution because LBD conformation in the context of the full-length receptor might be influenced significantly by other domains (Lau & Roux, 2011; Ylilauri & Pentikainen, 2012; Hansen et al. 2013).
Unliganded (apo) or antagonist bound structures of S1S2 – models of the LBD in the iGluR closed state – typically adopt the maximally open clamshell conformation (Fig. 2B). In contrast, S1S2 structures in complex with full agonists – models of LBD in the iGluR open state – often have the maximally closed clamshell conformation where D2 undergoes ∼25°-rotation towards D1 (Fig. 2C). Partial agonists, ligands that have only partial efficacy in eliciting iGluR currents compared to full agonists, often induce intermediate clamshell conformations, as shown in both AMPA (Jin et al. 2003) and KA (Mayer, 2005; Nayeem et al. 2011) receptors. Comparison of different GluA2 AMPA receptor S1S2 crystal structures resulted in one of the earliest structural hypotheses of activation, namely that the agonist-induced LBD clamshell closure leads to opening of the ion channel and that the degree of clamshell closure is proportional to the extent of iGluR activation (Armstrong & Gouaux, 2000). The back-to-back dimer arrangement of LBDs held together by the D1–D1 interface, first discovered in the S1S2 crystal structures and later recapitulated in the full-length GluA2 structure, elegantly explained how the closure of individual clamshells can cause separation of the D2 lobes, in turn leading to opening of the ion channel (Fig. 2B and C, Supplemental Movie 1).
Since the first published model of LBD (Armstrong et al. 1998), numerous S1S2 structures, apo (unliganded) or bound to different ligands, have become available, covering the whole spectrum of clamshell conformations from maximally open to maximally closed. The increasing number of available S1S2 structures has made it obvious that, in contradiction to the original hypothesis (Armstrong & Gouaux, 2000), a single ligand can produce structures of isolated LBD with different clamshell closures (Maltsev et al. 2008; Poon et al. 2011), while ligands producing different functional effects can induce identical clamshell closures (Inanobe et al. 2005; Ahmed et al. 2011; Poon et al. 2011; Hansen et al. 2013). Moreover, a rich diversity of LBD conformations, of which only a small portion is represented by the S1S2 crystal structures and consistent with the original hypothesis, have been revealed by studies using NMR (Fenwick & Oswald, 2010; Ahmed et al. 2013), single-molecule fluorescence resonance energy transfer (FRET; Landes et al. 2011; Ramaswamy et al. 2012), solution X-ray scattering (Madden et al. 2005), chemical crosslinking (Plested & Mayer, 2009) and molecular dynamics simulations (Lau & Roux, 2007, 2011; Postila et al. 2011; Ylilauri & Pentikainen, 2012; Yao et al. 2013).
The complicated structural dynamics of LBD can in part be reconciled by dividing the activation process into multiple steps, including binding of a ligand, LBD clamshell closure and formation of hydrogen bonds across the lobe interface (Ahmed et al. 2013). Only a weak correlation has been established between the free energy associated with LBD closure and the extent of LBD closure observed in crystal structures of GluA2, suggesting that the extent of closure, by itself, cannot account for the free energy associated with the protein's conformational transition (Lau & Roux, 2011). Rather, the extent of iGluR activation depends on the probability of the LBD clamshell to occupy its maximally closed conformation (Zhang et al. 2008; Ahmed et al. 2011; Landes et al. 2011; Lau & Roux, 2011; Maclean et al. 2011). According to this new view, the efficacy of a ligand to activate iGluR depends on its ability to stabilize the maximally closed LBD clamshell conformation. Additional tuning of iGluR activation might occur via effects of agonists on the LBD dimer interface (Nayeem et al. 2011).
While the principle activation mechanism is likely to be shared across all iGluRs, some features are certainly subtype specific. A striking example is NMDA receptors that typically have a single conductance level and concerted contribution of subunits to channel opening (Banke & Traynelis, 2003; Kussius & Popescu, 2009) versus non-NMDA receptors that demonstrate multiple single-channel conductances contributed by individual subunits (Rosenmund et al. 1998; Smith & Howe, 2000; Jin et al. 2003; Poon et al. 2010, 2011; Prieto & Wollmuth, 2010). Computed conformational free energy landscapes suggested that agonists of NMDA receptors bind via a conformational selection mechanism, while agonists of AMPA receptors bind via an induced-fit mechanism (Yao et al. 2013). The structural bases underlying differences between NMDA and non-NMDA receptors are not yet understood, but might involve ATD–LBD interdomain interactions (Hansen et al. 2013).
Gating initiation domain: LBD – desensitization
Desensitization – a gating process that is typically slower than activation – leads to closure of the ion channel pore and appears as a reduction of iGluR-mediated currents in the continuous presence of glutamate (Fig. 2A). Desensitization represents a natural way of suppressing iGluR activity to protect neurons from the excessive entry of excitotoxic calcium. Similar to activation, crystal structures of S1S2 have played a crucial role in developing current models of desensitization. In AMPA receptors, allosteric modulators, such as cyclothiazide, aniracetam and CX614, attenuate or block desensitization, presumably by binding at and stabilizing the LBD intradimer interface (Sun et al. 2002; Jin et al. 2005). Similarly, covalent crosslinks or single point mutations strengthening/perturbing the LBD intradimer interface in AMPA (Sun et al. 2002) or KA (Weston et al. 2006; Nayeem et al. 2009) receptors reduce/enhance desensitization, respectively. It has been concluded that desensitization occurs through a rearrangement of the dimer interface that disengages the agonist-induced conformational change in the LBD from the ion channel gate (Sun et al. 2002).
Experiments on crosslinking the D2 lobes of GluA2 S1S2 via the S729C substituted cysteines further examined the decoupling of agonist binding from ion channel gating (Armstrong et al. 2006). In the crosslinked S1S2, the individual clamshells maintain their maximally closed conformation, similar to the open state, while the D1 lobes undergo significant separation (Fig. 2D). According to this model, desensitization leads to rupture of the D1–D1 interface, which allows the D2 lobes and the linkers to the ion channel to adopt a closed state-like conformation (Supplemental Movie 2).
Rupture of the D1–D1 interface during desensitization is consistent with luminescence resonance energy transfer measurements in AMPA (Gonzalez et al. 2010) and NMDA receptors (Rambhadran et al. 2010). In KA receptors, the stability of the LBD dimer interface depends on the occupancy of the ion binding sites it harbours (Plested & Mayer, 2007; Plested et al. 2008; Nayeem et al. 2009; Veran et al. 2012; Dawe et al. 2013). A complete rupture of the intradimer interface and separation of LBDs during desensitization was proposed for GluK2 KA receptors (Schauder et al. 2013).
On the other hand, GluN1–GluN2A NMDA receptors with the crosslinked upper D1 lobes had intact desensitization but their activation was deeply impaired: their open probabilities were lowered 200-fold due to increased barriers to activation and unstable open states (Borschel et al. 2011). In KA receptors, covalent crosslinking of the dimer interface prevented access to the main open state but permitted lower conductance states, suggesting that significant rearrangements of the dimer interface are also required for activation (Daniels et al. 2013). Mutations of non-conserved residues in the D2 lobe of GluA2 distal from the intradimer interface conferred slow recovery from desensitization on AMPA receptors (Carbone & Plested, 2012). One of these mutations, E713T, increased the stability of the isolated S1S2 measured by thermal unfolding (Ahmed et al. 2013), possibly due to altered interaction between hydrophobic elements of D2 that might affect both AMPA receptor desensitization and activation.
Given the above examples of seemingly conflicting results, the LBD dimer interface may have adapted to fulfill different tasks as distinct iGluR subtypes emerged during evolution (Daniels et al. 2013). It is clear that more structural and functional work is required to fully understand the role of LBD in iGluR gating.
Gating effector domain: ion channel
The ion channel – the iGluR gating effector domain – has only been characterized structurally within the context of the full-length GluA2 receptor (Fig. 1B). The TMD of each iGluR subunit contributes three transmembrane helices M1, M3 and M4 and a reentrant loop M2 containing a C-terminal helical region and an N-terminal extended region that lines the ion channel pore (Fig. 3A). A short pre-M1 helix oriented nearly parallel to the membrane acts as a cuff around the extracellular portion of the ion channel and serves as a binding site for non-competitive inhibitors (Balannik et al. 2005) and allosteric regulators (Ogden & Traynelis, 2013). Since GluA2 was crystallized in the presence of competitive antagonist ZK, the ion channel is in an apparently closed conformation (Fig. 3C). The narrowest portion of the pore is formed by the bundle crossing of M3 helices. This region bears high structural homology to the corresponding region in K+ channels (Fig. 3B) and similarly was proposed to serve as an activation gate (Chang and Kuo, 2008; Moore et al. 2013). Whether the extended portion of M2, which defines iGluR permeation and channel block but is apparently disordered in the GluA2 structure, also contributes to the activation gate (Sobolevsky et al. 2002) remains uncertain.
Figure 3. Ion channel.
A, GluA2 ion channel (3KG2) viewed parallel to membrane. The subunits are coloured similarly to Fig. 1B. The transmembrane segments M1 to M4 and the calf helix pre-M1 are labelled. B, superposition of the GluA2 channel (3KG2, cyan) and KcsA (1BL8, orange). C, GluA2 channel viewed from the extracellular side of membrane. The diagonal pairs of subunits, A/C and B/D, are shown in light green and purple, respectively. Molecular surface representation emphasizes that the channel is in the closed conformation. D, Shaker K+ channel in the open state (2A79) viewed from the intracellular side of membrane. Colouring of subunits is similar to the GluA2 channel in C. Comparing the structures of the closed GluA2 channel in C and the open Shaker channel in D, one can imagine how transmembrane helices of iGluR can bend and splay away from the central axis of the channel, mimicking the iris-like opening of K+ channels.
The structure of the iGluR channel in the open state is not yet available. During activation, a significant portion of the channel may transition from fourfold symmetry to twofold symmetry (Sobolevsky et al. 2004) but the overall character of conformational changes will likely follow the iris-type opening in structurally homologous K+ channels (cf. Fig. 3C and D). There is no structure of the iGluR channel in the desensitized state either, but its non-conducting conformation is expected to be similar to the closed state.
Gating transmission domain: LBD–TMD linkers
The LBD–TMD linkers – the iGluR gating transmission domain – include three types of polypeptides, S1–M1, M3–S2 and S2–M4 (Fig. 1D), that convert ligand-induced conformational changes in LBD to opening/closure of the ion channel. Since these linkers also convert twofold rotational symmetry of the extracellular domain to fourfold rotational symmetry of the ion channel, one diagonal pair of each linker type differs significantly from the second diagonal pair. This is especially evident for the M3–S2 linkers, which not only have different conformations, but also distinct secondary structures; the M3 helices of subunits A and C are 4 residues (one α-helical turn) longer than those of subunits B and D. The three linker types all play an important role in gating, and restraining their movement results in impaired iGluR function (Yelshansky et al. 2004; Talukder et al. 2011; Talukder & Wollmuth, 2011; Kazi et al. 2013). The LBD–TMD linkers also form the entry portals for the permeant ions, and their amino acid composition affects the binding sites and permeation of Ca2+ through the channel pore (Watanabe et al. 2002; Dai & Zhou, 2013).
Gating modulatory domain: ATD
The ATD – the iGluR gating modulatory domain – plays an important role in the allosteric modulation of NMDA receptors. Allosteric modulators that interact with NMDA receptors include polyamines and GluN2-specific agents like ifenprodil and Zn2+ (Mony et al. 2009; Furukawa, 2012). Recent advances in crystallization of NMDA receptor ATDs successfully identified binding sites for Zn2+ inside the clamshell cleft of GluN2B (Karakas et al. 2009) and for ifenprodil and related compounds at the GluN1–GluN2B interface (Karakas et al. 2011). Both GluN1 and GluN2 ATDs are mobile regulatory domains and are dynamically involved in NMDA receptor allosteric modulation (Gielen et al. 2009; Yuan et al. 2009; Zhu et al. 2013). Allosteric modulators acting at non-NMDA ATDs have not yet been identified. In fact, extensive interfaces between the upper and lower lobes of ATD dimers typically observed in crystal structures of isolated AMPA (Jin et al. 2009) and KA (Kumar et al. 2009; Kumar & Mayer, 2010) receptor ATDs essentially immobilize individual ATD clamshells. Nevertheless, the somewhat different clamshell conformations observed in GluA3 ATD crystal structures, the normal mode analysis and electron density detected in the interlobe cleft of a high resolution crystal structure of GluA2 ATD (Sukumaran et al. 2011) argue for a possibility that such modulators might be identified in the future.
The transmission of allosteric modulatory signals from ATD to LBD must occur through the ATD–LBD linkers and ATD–LBD interfaces. Perhaps, the latter ones play a more important role in AMPA receptors, as a six-residue deletion in the ATD–LBD linker did not produce appreciable changes in GluA2 structure and function (Sobolevsky et al. 2009). Given the significantly different conformations and dynamic properties of ATDs in NMDA and non-NMDA receptors (Furukawa, 2012), the structure and role of ATD–LBD linkers and interfaces in ATD–LBD communication might be strongly subtype specific. Structural mechanisms that transmit allosteric modulation from ATD to the ion channel have yet to be identified for any iGluR subtype. Further structural and functional experiments are needed to solve this puzzle.
Model of full-length iGluR gating
In summary, a simplified model of iGluR gating at the level of the full-length receptor (Fig. 4) can be constructed based on the following assumptions: (1) the closed state is represented by the antagonist-bound structure of the full-length GluA2; (2) in the open and desensitized states, the LBD has conformations of glutamate-bound S1S2 with and without the S729C mutation, respectively; (3) the ATD dimer of dimers does not change conformation and stays the same in all three conformational states; and (4) in the desensitized state, the ion channel has a conformation identical to the closed state, but has a Shaker-like conformation in the open state. According to this model, the full-length iGluR undergoes twisting and shortening upon activation and untwisting and elongation during desensitization (Supplemental Movie 3).
Figure 4. Structural model of iGluR gating.
Shown is the full-length iGluR in the presumed closed, open and desensitized states. The closed state is represented by the GluA2 crystal structure (3KG2), while open and desensitized states are putative conformations constructed based on a set of assumptions (see main text). Simulation of opening movements of the ion channel segments homologous to the corresponding segments of the Shaker K+ channel (2A79) and docking of the ion channel, LBDs and ATDs relative to each other in the open and desensitized states were carried out using the program Superpose (CCP4 program suite). The diagonal pairs of subunits, A/C and B/D, are shown in light green and purple, respectively. Vertical and equatorial arrow symbols indicate shortening/elongation and twisting/untwisting changes in the structure, respectively. The arrow thickness corresponds to the motion strength: the thicker the arrow the stronger motion. Note, twisting and shortening of the structure occur during opening, while untwisting and elongation during desensitization (see Supplemental Movie 3). Transitions between the closed, open and desensitized states that are shown as unidirectional can potentially be reversed.
While this model almost certainly represents an oversimplification of reality, it can nevertheless serve as a guide for deriving experimentally testable hypotheses. Further development of the model in terms of energetic feasibility will require molecular modelling. Molecular modelling studies have already made a number of important predictions including vertical movement of TMDs during gating in AMPA receptors (Dong & Zhou, 2011) and a stronger contribution of GluN2 compared to GluN1 to NMDA receptor gating (Dai & Zhou, 2013). They have also identified molecular determinants of the toxin binding site in Ca2+-permeable AMPA receptors and the mechanism of toxin trapping in the channel (Barygin et al. 2011), distinguished five groups of residues in AMPA receptors that regulate glutamate binding affinity (Su et al. 2013) and revealed the structure of the extracellular Ca2+ binding site that contributes to high Ca2+ permeability of NMDA receptor channels (Dai & Zhou, 2013). Model-predicted conformational dynamics can be tested experimentally using various structural and functional approaches including electrophysiology, X-ray crystallography, NMR, site-directed mutagenesis and FRET. Future modifications and corrections to this oversimplified model will allow us to gain a more nuanced understanding of the iGluR gating mechanism.
Conclusions
Based on structural and functional work of the last two decades, a fuzzy picture of iGluR gating in the full-length receptor begins to appear. There are still more questions than answers; for example: What do full-length structures of NMDA and KA receptors look like? What is the arrangement of subunits in heteromeric iGluRs? What do structures in activation states other than the closed state look like? What is the structural mechanism of iGluR assembly? Are there allosteric regulators acting at the ATD domains of non-NMDA receptors? What are the structural mechanisms of iGluR interaction with auxiliary subunits? What is the structural origin of subconductance states? We are entering an exciting era of deciphering the fundamental structural principles of iGluR function. Better understanding of these principles will aid the development of new drug design strategies for the treatment of numerous neurological diseases.
Acknowledgments
The author thanks Eric Green, Maria Yelshansky and Kei Saotome for valuable comments on the manuscript. Structural illustrations were made using the PyMOL Molecular Graphics System (Schrodinger, LLC).
Glossary
- ATD
amino-terminal domain
- EM
electron microscopy
- iGluR
ionotropic glutamate receptor
- KA
kainate
- LBD
ligand-binding domain
- TMD
transmembrane domain.
Biography
Alexander Sobolevsky (Columbia University) earned his PhD in biophysics in 1999 from the Moscow Institute of Physics and Technology, working under the guidance of Professor Boris Khodorov. He held his first postdoctoral position in 2000, studying physiology and neuroscience with Dr LonnieWollmuth at the State University of New York, Stony Brook. He continued his training in biochemistry and biophysics with Dr Eric Gouaux, first at Columbia University and then at the Oregon Health and Science University. He joined Columbia University's faculty in 2010 as an assistant professor of biochemistry and molecular biophysics, focusing on structure and function of ion channels.
Additional information
Competing interests
None declared.
Funding
A.I.S. was supported by the Klingenstein Fellowship Award in the Neurosciences and by National Institutes of Health grant NS083660.
Supporting Information
Disclaimer: Supporting information has been peer-reviewed but not copyedited.
Supplemental Fig. 1
Supplemental Movie 1
Supplemental Movie 2
Supplemental Movie 3
References
- Ahmed AH, Ptak CP, Fenwick MK, Hsieh CL, Weiland GA. Oswald RE. Dynamics of cleft closure of the GluA2 ligand-binding domain in the presence of full and partial agonists revealed by hydrogen–deuterium exchange. J Biol Chem. 2013;288:27658–27666. doi: 10.1074/jbc.M113.495564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahmed AH, Wang S, Chuang HH. Oswald RE. Mechanism of AMPA receptor activation by partial agonists: disulfide trapping of closed lobe conformations. J Biol Chem. 2011;286:35257–35266. doi: 10.1074/jbc.M111.269001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Armstrong N. Gouaux E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron. 2000;28:165–181. doi: 10.1016/s0896-6273(00)00094-5. [DOI] [PubMed] [Google Scholar]
- Armstrong N, Jasti J, Beich-Frandsen M. Gouaux E. Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor. Cell. 2006;127:85–97. doi: 10.1016/j.cell.2006.08.037. [DOI] [PubMed] [Google Scholar]
- Armstrong N, Sun Y, Chen GQ. Gouaux E. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature. 1998;395:913–917. doi: 10.1038/27692. [DOI] [PubMed] [Google Scholar]
- Balannik V, Menniti FS, Paternain AV, Lerma J. Stern-Bach Y. Molecular mechanisms of AMPA receptor noncompetitive antagonism. Neuron. 2005;48:279–288. doi: 10.1016/j.neuron.2005.09.024. [DOI] [PubMed] [Google Scholar]
- Banke TG. Traynelis SF. Activation of NR1/NR2B NMDA receptors. Nat Neurosci. 2003;6:144–152. doi: 10.1038/nn1000. [DOI] [PubMed] [Google Scholar]
- Barygin OI, Grishin EV. Tikhonov DB. Argiotoxin in the closed AMPA receptor channel: experimental and modelling study. Biochemistry. 2011;50:8213–8220. doi: 10.1021/bi200617v. [DOI] [PubMed] [Google Scholar]
- Borschel WF, Murthy SE, Kasperek EM. Popescu GK. NMDA receptor activation requires remodelling of intersubunit contacts within ligand-binding heterodimers. Nat Commun. 2011;2:498. doi: 10.1038/ncomms1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowie D. Ionotropic glutamate receptors & CNS disorders. CNS Neurol Disord Drug Targets. 2008;7:129–143. doi: 10.2174/187152708784083821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowie D. Ion-dependent gating of kainate receptors. J Physiol. 2010;588:67–81. doi: 10.1113/jphysiol.2009.178863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carbone AL. Plested AJ. Coupled control of desensitization and gating by the ligand binding domain of glutamate receptors. Neuron. 2012;74:845–857. doi: 10.1016/j.neuron.2012.04.020. [DOI] [PubMed] [Google Scholar]
- Chang HR. Kuo CC. The activation gate and gating mechanism of the NMDA receptor. J Neurosci. 2008;28:1546–1556. doi: 10.1523/JNEUROSCI.3485-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clayton A, Siebold C, Gilbert RJC, Sutton GC, Harlos K, McIlhinney RAJ, Jones EY. Aricescu AR. Crystal structure of the GluR2 amino-teminal domain provides insights into the architecture and assembly of ionotropic glutamate receptors. J Mol Biol. 2009;392:1125–1132. doi: 10.1016/j.jmb.2009.07.082. [DOI] [PubMed] [Google Scholar]
- Dai J. Zhou HX. An NMDA receptor gating mechanism developed from MD simulations reveals molecular details underlying subunit-specific contributions. Biophys J. 2013;104:2170–2181. doi: 10.1016/j.bpj.2013.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Daniels BA, Andrews ED, Aurousseau MR, Accardi MV. Bowie D. Crosslinking the ligand-binding domain dimer interface locks kainate receptors out of the main open state. J Physiol. 2013;591:3873–3885. doi: 10.1113/jphysiol.2013.253666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dawe GB, Musgaard M, Andrews ED, Daniels BA, Aurousseau MR, Biggin PC. Bowie D. Defining the structural relationship between kainate-receptor deactivation and desensitization. Nat Struct Mol Biol. 2013;20:1054–1061. doi: 10.1038/nsmb.2654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dong H. Zhou HX. Atomistic mechanism for the activation and desensitization of an AMPA-subtype glutamate receptor. Nat Commun. 2011;2:354. doi: 10.1038/ncomms1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fenwick MK. Oswald RE. On the mechanisms of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor binding to glutamate and kainate. J Biol Chem. 2010;285:12334–12343. doi: 10.1074/jbc.M109.086371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Furukawa H. Structure and function of glutamate receptor amino terminal domains. J Physiol. 2012;590:63–72. doi: 10.1113/jphysiol.2011.213850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gielen M, Siegler Retchless B, Mony L, Johnson JW. Paoletti P. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature. 2009;459:703–707. doi: 10.1038/nature07993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gonzalez J, Du M, Parameshwaran K, Suppiramaniam V. Jayaraman V. Role of dimer interface in activation and desensitization in AMPA receptors. Proc Natl Acad Sci U S A. 2010;107:9891–9896. doi: 10.1073/pnas.0911854107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gouaux E. Structure and function of AMPA receptors. J Physiol. 2004;554:249–253. doi: 10.1113/jphysiol.2003.054320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hansen KB, Tajima N, Risgaard R, Perszyk RE, Jorgensen L, Vance KM, Ogden KK, Clausen RP, Furukawa H. Traynelis SF. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-d-aspartate receptors. Mol Pharmacol. 2013;84:114–127. doi: 10.1124/mol.113.085803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herguedas B, Krieger J. Greger IH. Receptor heteromeric assembly-how it works and why it matters: the case of ionotropic glutamate receptors. Prog Mol Biol Transl Sci. 2013;117:361–386. doi: 10.1016/B978-0-12-386931-9.00013-1. [DOI] [PubMed] [Google Scholar]
- Inanobe A, Furukawa H. Gouaux E. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors. Neuron. 2005;47:71–84. doi: 10.1016/j.neuron.2005.05.022. [DOI] [PubMed] [Google Scholar]
- Jackson AC. Nicoll RA. The expanding social network of ionotropic glutamate receptors: TARPs and other transmembrane auxiliary subunits. Neuron. 2011;70:178–199. doi: 10.1016/j.neuron.2011.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jin R, Banke T, Mayer ML, Traynelis SF. Gouaux E. Structural basis for partial agonist action at ionotropic glutamate receptors. Nat Neurosci. 2003;6:803–810. doi: 10.1038/nn1091. [DOI] [PubMed] [Google Scholar]
- Jin R, Clark S, Weeks AM, Dudman JT, Gouaux E. Partin KM. Mechanism of positive allosteric modulators acting on AMPA receptors. J Neurosci. 2005;25:9027–9036. doi: 10.1523/JNEUROSCI.2567-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jin R, Singh SK, Gu S, Furukawa H, Sobolevsky AI, Zhou J, Jin Y. Gouaux E. Crystal structure and association behaviour of the GluR2 amino-terminal domain. EMBO J. 2009;28:1812–1823. doi: 10.1038/emboj.2009.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karakas E, Simorowski N. Furukawa H. Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J. 2009;28:3910–3920. doi: 10.1038/emboj.2009.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karakas E, Simorowski N. Furukawa H. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature. 2011;475:249–253. doi: 10.1038/nature10180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kazi R, Gan Q, Talukder I, Markowitz M, Salussolia CL. Wollmuth LP. Asynchronous movements prior to pore opening in NMDA receptors. J Neurosci. 2013;33:12052–12066. doi: 10.1523/JNEUROSCI.5780-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar J. Mayer ML. Crystal structures of the glutamate receptor ion channel GluK3 and GluK5 amino-terminal domains. J Mol Biol. 2010;404:680–696. doi: 10.1016/j.jmb.2010.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar J. Mayer ML. Functional insights from glutamate receptor ion channel structures. Annu Rev Physiol. 2013;75:313–337. doi: 10.1146/annurev-physiol-030212-183711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar J, Schuck P, Jin R. Mayer ML. The N-terminal domain of GluR6-subtype glutamate receptor ion channels. Nat Struct Mol Biol. 2009;16:631–638. doi: 10.1038/nsmb.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar J, Schuck P. Mayer ML. Structure and assembly mechanism for heteromeric kainate receptors. Neuron. 2011;71:319–331. doi: 10.1016/j.neuron.2011.05.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kussius CL. Popescu GK. Kinetic basis of partial agonism at NMDA receptors. Nat Neurosci. 2009;12:1114–1120. doi: 10.1038/nn.2361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landes CF, Rambhadran A, Taylor JN, Salatan F. Jayaraman V. Structural landscape of isolated agonist-binding domains from single AMPA receptors. Nat Chem Biol. 2011;7:168–173. doi: 10.1038/nchembio.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lau AY. Roux B. The free energy landscapes governing conformational changes in a glutamate receptor ligand-binding domain. Structure. 2007;15:1203–1214. doi: 10.1016/j.str.2007.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lau AY. Roux B. The hidden energetics of ligand binding and activation in a glutamate receptor. Nat Struct Mol Biol. 2011;18:283–287. doi: 10.1038/nsmb.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lau AY, Salazar H, Blachowicz L, Ghisi V, Plested AJ. Roux B. A conformational intermediate in glutamate receptor activation. Neuron. 2013;79:492–503. doi: 10.1016/j.neuron.2013.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lopez MN, Wilding TJ. Huettner JE. Q/R site interactions with the M3 helix in GluK2 kainate receptor channels revealed by thermodynamic mutant cycles. J Gen Physiol. 2013;142:225–239. doi: 10.1085/jgp.201311000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu W. Roche KW. Posttranslational regulation of AMPA receptor trafficking and function. Curr Opin Neurobiol. 2012;22:470–479. doi: 10.1016/j.conb.2011.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maclean DM, Wong AY, Fay AM. Bowie D. Cations but not anions regulate the responsiveness of kainate receptors. J Neurosci. 2011;31:2136–2144. doi: 10.1523/JNEUROSCI.4314-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Madden DR, Armstrong N, Svergun D, Perez J. Vachette P. Solution X-ray scattering evidence for agonist- and antagonist-induced modulation of cleft closure in a glutamate receptor ligand-binding domain. J Biol Chem. 2005;280:23637–23642. doi: 10.1074/jbc.M414523200. [DOI] [PubMed] [Google Scholar]
- Maltsev AS, Ahmed AH, Fenwick MK, Jane DE. Oswald RE. Mechanism of partial agonism at the GluR2 AMPA receptor: Measurements of lobe orientation in solution. Biochemistry. 2008;47:10600–10610. doi: 10.1021/bi800843c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mayer ML. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity. Neuron. 2005;45:539–552. doi: 10.1016/j.neuron.2005.01.031. [DOI] [PubMed] [Google Scholar]
- Midgett CR, Gill A. Madden DR. Domain architecture of a calcium-permeable AMPA receptor in a ligand-free conformation. Front Mol Neurosci. 2012;4:56. doi: 10.3389/fnmol.2011.00056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mony L, Kew JN, Gunthorpe MJ. Paoletti P. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol. 2009;157:1301–1317. doi: 10.1111/j.1476-5381.2009.00304.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moore BS, Mirshahi UL, Ebersole TL. Mirshahi T. A conserved mechanism for gating in an ionotropic glutamate receptor. J Biol Chem. 2013;288:18842–18852. doi: 10.1074/jbc.M113.465187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakagawa T, Cheng Y, Ramm E, Sheng M. Walz T. Structure and different conformational states of native AMPA receptor complexes. Nature. 2005;433:545–549. doi: 10.1038/nature03328. [DOI] [PubMed] [Google Scholar]
- Nayeem N, Mayans O. Green T. Conformational flexibility of the ligand-binding domain dimer in kainate receptor gating and desensitization. J Neurosci. 2011;31:2916–2924. doi: 10.1523/JNEUROSCI.4771-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nayeem N, Zhang Y, Schweppe DK, Madden DR. Green T. A nondesensitizing kainate receptor point mutant. Mol Pharmacol. 2009;76:534–542. doi: 10.1124/mol.109.056598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ogden KK. Traynelis SF. New advances in NMDA receptor pharmacology. Trends Pharmacol Sci. 2011;32:726–733. doi: 10.1016/j.tips.2011.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ogden KK. Traynelis SF. Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-d-aspartate receptors. Mol Pharmacol. 2013;83:1045–1056. doi: 10.1124/mol.113.085209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paoletti P. Molecular basis of NMDA receptor functional diversity. Eur J Neurosci. 2011;33:1351–1365. doi: 10.1111/j.1460-9568.2011.07628.x. [DOI] [PubMed] [Google Scholar]
- Paoletti P, Bellone C. Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013;14:383–400. doi: 10.1038/nrn3504. [DOI] [PubMed] [Google Scholar]
- Plested AJ. Mayer ML. Structure and mechanism of kainate receptor modulation by anions. Neuron. 2007;53:829–841. doi: 10.1016/j.neuron.2007.02.025. [DOI] [PubMed] [Google Scholar]
- Plested AJ. Mayer ML. AMPA receptor ligand binding domain mobility revealed by functional cross linking. J Neurosci. 2009;29:11912–11923. doi: 10.1523/JNEUROSCI.2971-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Plested AJ, Vijayan R, Biggin PC. Mayer ML. Molecular basis of kainate receptor modulation by sodium. Neuron. 2008;58:720–735. doi: 10.1016/j.neuron.2008.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poon K, Ahmed AH, Nowak LM. Oswald RE. Mechanisms of modal activation of GluA3 receptors. Mol Pharmacol. 2011;80:49–59. doi: 10.1124/mol.111.071688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poon K, Nowak LM. Oswald RE. Characterizing single-channel behaviour of GluA3 receptors. Biophys J. 2010;99:1437–1446. doi: 10.1016/j.bpj.2010.06.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Popescu G. Auerbach A. Modal gating of NMDA receptors and the shape of their synaptic response. Nat Neurosci. 2003;6:476–483. doi: 10.1038/nn1044. [DOI] [PubMed] [Google Scholar]
- Popescu GK. Modes of glutamate receptor gating. J Physiol. 2012;590:73–91. doi: 10.1113/jphysiol.2011.223750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Postila PA, Ylilauri M. Pentikainen OT. Full and partial agonism of ionotropic glutamate receptors indicated by molecular dynamics simulations. J Chem Inf Model. 2011;51:1037–1047. doi: 10.1021/ci2000055. [DOI] [PubMed] [Google Scholar]
- Prieto ML. Wollmuth LP. Gating modes in AMPA receptors. J Neurosci. 2010;30:4449–4459. doi: 10.1523/JNEUROSCI.5613-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramaswamy S, Cooper D, Poddar N, MacLean DM, Rambhadran A, Taylor JN, Uhm H, Landes CF. Jayaraman V. Role of conformational dynamics in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor partial agonism. J Biol Chem. 2012;287:43557–43564. doi: 10.1074/jbc.M112.371815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rambhadran A, Gonzalez J. Jayaraman V. Subunit arrangement in N-methyl-d-aspartate (NMDA) receptors. J Biol Chem. 2010;285:15296–15301. doi: 10.1074/jbc.M109.085035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ren H, Zhao Y, Wu M. Peoples RW. A novel alcohol-sensitive position in the N-methyl-d-aspartate receptor GluN2A subunit M3 domain regulates agonist affinity and ion channel gating. Mol Pharmacol. 2013;84:501–510. doi: 10.1124/mol.113.085993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robert A. Howe JR. How AMPA receptor desensitization depends on receptor occupancy. J Neurosci. 2003;23:847–858. doi: 10.1523/JNEUROSCI.23-03-00847.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenmund C, Stern-Bach Y. Stevens CF. The tetrameric structure of a glutamate receptor channel. Science. 1998;280:1596–1599. doi: 10.1126/science.280.5369.1596. [DOI] [PubMed] [Google Scholar]
- Salussolia CL, Gan Q, Kazi R, Singh P, Allopenna J, Furukawa H. Wollmuth LP. A eukaryotic specific transmembrane segment is required for tetramerization in AMPA receptors. J Neurosci. 2013;33:9840–9845. doi: 10.1523/JNEUROSCI.2626-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schauder DM, Kuybeda O, Zhang J, Klymko K, Bartesaghi A, Borgnia MJ, Mayer ML. Subramaniam S. Glutamate receptor desensitization is mediated by changes in quaternary structure of the ligand binding domain. Proc Natl Acad Sci U S A. 2013;110:5921–5926. doi: 10.1073/pnas.1217549110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siegler Retchless B, Gao W. Johnson JW. A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction. Nat Neurosci. 2012;15:406–413. doi: 10.1038/nn.3025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith TC. Howe JR. Concentration-dependent substate behaviour of native AMPA receptors. Nat Neurosci. 2000;3:992–997. doi: 10.1038/79931. [DOI] [PubMed] [Google Scholar]
- Sobolevsky AI, Beck C. Wollmuth LP. Molecular rearrangements of the extracellular vestibule in NMDAR channels during gating. Neuron. 2002;33:75–85. doi: 10.1016/s0896-6273(01)00560-8. [DOI] [PubMed] [Google Scholar]
- Sobolevsky AI, Rosconi MP. Gouaux E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature. 2009;462:745–756. doi: 10.1038/nature08624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sobolevsky AI, Yelshansky MV. Wollmuth LP. The outer pore of the glutamate receptor channel has 2-fold rotational symmetry. Neuron. 2004;41:367–378. doi: 10.1016/s0896-6273(04)00008-x. [DOI] [PubMed] [Google Scholar]
- Su JG, Du HJ, Hao R, Xu XJ, Li CH, Chen WZ. Wang CX. Identification of functionally key residues in AMPA receptor with a thermodynamic method. J Phys Chem B. 2013;117:8689–8696. doi: 10.1021/jp402290t. [DOI] [PubMed] [Google Scholar]
- Sukumaran M, Rossmann M, Shrivastava I, Dutta A, Bahar I. Greger IH. Dynamics and allosteric potential of the AMPA receptor N-terminal domain. EMBO J. 2011;30:972–982. doi: 10.1038/emboj.2011.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun Y, Olson R, Horning M, Armstrong N, Mayer M. Gouaux E. Mechanism of glutamate receptor desensitization. Nature. 2002;417:245–253. doi: 10.1038/417245a. [DOI] [PubMed] [Google Scholar]
- Talukder I, Kazi R. Wollmuth LP. GluN1-specific redox effects on the kinetic mechanism of NMDA receptor activation. Biophys J. 2011;101:2389–2398. doi: 10.1016/j.bpj.2011.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Talukder I. Wollmuth LP. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening. J Gen Physiol. 2011;138:179–194. doi: 10.1085/jgp.201110623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62:405–496. doi: 10.1124/pr.109.002451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vance KM, Hansen KB. Traynelis SF. Modal gating of GluN1/GluN2D NMDA receptors. Neuropharmacology. 2013;71:184–190. doi: 10.1016/j.neuropharm.2013.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Veran J, Kumar J, Pinheiro PS, Athane A, Mayer ML, Perrais D. Mulle C. Zinc potentiates GluK3 glutamate receptor function by stabilizing the ligand binding domain dimer interface. Neuron. 2012;76:565–578. doi: 10.1016/j.neuron.2012.08.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watanabe J, Beck C, Kuner T, Premkumar LS. Wollmuth LP. DRPEER: a motif in the extracellular vestibule conferring high Ca2+ flux rates in NMDA receptor channels. J Neurosci. 2002;22:10209–10216. doi: 10.1523/JNEUROSCI.22-23-10209.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weston MC, Schuck P, Ghosal A, Rosenmund C. Mayer ML. Conformational restriction blocks glutamate receptor desensitization. Nature Struct Mol Biol. 2006;13:1120–1127. doi: 10.1038/nsmb1178. [DOI] [PubMed] [Google Scholar]
- Yao Y, Belcher J, Berger AJ, Mayer ML. Lau AY. Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics. Structure. 2013;21:1788–1799. doi: 10.1016/j.str.2013.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yelshansky MV, Sobolevsky AI, Jatzke C. Wollmuth LP. Block of AMPA receptor desensitization by a point mutation outside the ligand-binding domain. J Neurosci. 2004;24:4728–4736. doi: 10.1523/JNEUROSCI.0757-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ylilauri M. Pentikainen OT. Structural mechanism of N-methyl-d-aspartate receptor type 1 partial agonism. PLoS One. 2012;7:e47604. doi: 10.1371/journal.pone.0047604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yuan H, Hansen KB, Vance KM, Ogden KK. Traynelis SF. Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci. 2009;29:12045–12058. doi: 10.1523/JNEUROSCI.1365-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang W, Cho Y, Lolis E. Howe JR. Structural and single-channel results indicate that the rates of ligand binding domain closing and opening directly impact AMPA receptor gating. J Neurosci. 2008;28:932–943. doi: 10.1523/JNEUROSCI.3309-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu S, Stroebel D, Yao CA, Taly A. Paoletti P. Allosteric signalling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain. Nat Struct Mol Biol. 2013;20:477–485. doi: 10.1038/nsmb.2522. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental Fig. 1
Supplemental Movie 1
Supplemental Movie 2
Supplemental Movie 3